Literature DB >> 2897315

Induction of nesidioblastosis will reverse diabetes in Syrian golden hamster.

L Rosenberg1, W P Duguid, R A Brown, A I Vinik.   

Abstract

Nesidioblastosis, which is the formation of new islets and the differentiation of cells within the islets, represents part of the spectrum of hyperfunctioning states of the islets of Langerhans at the clinical level. Nesidioblastosis in the Syrian golden hamster can be induced by wrapping the head of the pancreas with cellophane tape. Ligation of the duct is not involved, and acinar cell atrophy does not occur. The purpose of this study was to determine whether the induction of nesidioblastosis could be used as a means of reversing streptozocin-induced diabetes. Outbred hamsters (n = 32), 8 wk of age, were rendered diabetic by treatment with 40 mg/kg i.p. streptozocin, administered daily for 3 days. Four days later, 16 animals chosen at random underwent laparotomy with cellophane wrapping of the pancreas. Before surgery, the serum glucose and insulin levels (means +/- SE) in the unoperated control animals (389.0 +/- 18.6, 33.9 +/- 3.8) did not differ from those in the animals awaiting the operation (373.2 +/- 18.6, 37.9 +/- 3.8). After 7 wk, 50% of the operated animals had serum glucose and insulin levels that were normal, compared to only 12% of the unoperated control animals (chi2 = 5.53, P less than .05). Islets from normoglycemic operated animals were characterized by increased numbers, including many small islets, positive immunoreactive insulin staining, and minimal vacuolation of cells. Islets from hyperglycemic operated hamsters and from the unoperated control animals were decreased in number and generally larger in size, demonstrated little or no immunoreactive insulin staining, and exhibited marked vacuolation of cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897315     DOI: 10.2337/diab.37.3.334

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  A role for islet neogenesis in curing diabetes.

Authors:  G L Pittenger; D Taylor-Fishwick; A I Vinik
Journal:  Diabetologia       Date:  2009-03-07       Impact factor: 10.122

2.  The patterns of beta-cell regeneration in untreated diabetic and insulin-treated diabetic Syrian hamsters after streptozotocin treatment.

Authors:  T Tomioka; H Fujii; M Hirota; K Ueno; P M Pour
Journal:  Int J Pancreatol       Date:  1991-05

Review 3.  Nesidioblastosis unravelled.

Authors:  R D Milner
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

4.  Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters.

Authors:  R Rafaeloff; G L Pittenger; S W Barlow; X F Qin; B Yan; L Rosenberg; W P Duguid; A I Vinik
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

5.  Mechanisms of action of islet neogenesis-associated protein: comparison of the full-length recombinant protein and a bioactive peptide.

Authors:  Maria Petropavlovskaia; Jamal Daoud; Jonathan Zhu; Mandana Moosavi; Jieping Ding; Julia Makhlin; Beatrice Assouline-Thomas; Lawrence Rosenberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-31       Impact factor: 4.310

Review 6.  Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies.

Authors:  Vimal Selvaraj; Jennifer M Plane; Ambrose J Williams; Wenbin Deng
Journal:  Trends Biotechnol       Date:  2010-02-09       Impact factor: 19.536

7.  Expression of Reg gene in the Syrian golden hamster pancreatic islet regeneration model.

Authors:  R Rafaeloff; S W Barlow; L Rosenberg; A I Vinik
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

8.  Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model.

Authors:  P M Pour; K Kazakoff
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

9.  Pancreatic regenerating protein I in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes.

Authors:  Martin Bluth; Cathy M Mueller; Joelle Pierre; Gordon Callender; Emad Kandil; Domenico Viterbo; Sophia L Fu; Akira Sugawara; Hiroshi Okamoto; Michael E Zenilman
Journal:  Pancreas       Date:  2008-11       Impact factor: 3.327

10.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.